Practical Neurology

July/August 2020

Neuromuscular Disorders

Featured

Duchenne Muscular Dystrophy

Craig Zaidman, MD

Pompe Disease

Jonathan Cauchi, MD

Muscle MRI for Neuromuscular Disorders

Stefan Nicolau, MD, and Elie Naddaf, MD

Transthyretin Familal Amyloid Neuropathy

Jordan Mayberry, MD; Lisa D. Hobson-Webb, MD; and Karissa Gable, MD

Porphyric Neuropathy

Rachana Gandhi Mehta, MD; Vanessa Baute Penry, MD; and Herbert Lloyd Bonkovsky, MD

Myasthenia Gravis Treatment

Vanessa Baute Penry, MD, and Rachana Gandhi Mehta, MD

Amyotrophic Lateral Sclerosis

Zachary S. Gillis, BS, and Michael S. Cartwright, MD, MS

Spinal Muscular Atrophy

Diana Castro, MD

In this issue

About The Cover Artist

Kathy Q. Parks celebrates the gift of artistic expression and its power to heal.

Kathy Q. Parks

Chief Medical Editor's Page

The Future of Neuromuscular Disorders is Now

The neuromuscular world as we know it is changing before our eyes.

Monika Krzesniak-Swinarska, MD

Cover Focus

Duchenne Muscular Dystrophy

Well-established corticosteroid therapy prolongs life, and potentially curative new treatments are in development.

Craig Zaidman, MD

Pompe Disease

New treatments, available and in development, underscore need for high degree of suspicion for Pompe disease in differential for weakness and respiratory difficulties.

Jonathan Cauchi, MD

Muscle MRI for Neuromuscular Disorders

Using muscle MRI to diagnose neuromuscular conditions requires awareness of different patterns of muscle involvement.

Stefan Nicolau, MD, and Elie Naddaf, MD

Transthyretin Familal Amyloid Neuropathy

Early detection can lead to earlier interventions that can slow disease progression significantly

Jordan Mayberry, MD; Lisa D. Hobson-Webb, MD; and Karissa Gable, MD

Porphyric Neuropathy

Timely diagnosis and treatment and new medications to prevent attacks provide more options for treating acute hepatic porphyrias.

Rachana Gandhi Mehta, MD; Vanessa Baute Penry, MD; and Herbert Lloyd Bonkovsky, MD

Myasthenia Gravis Treatment

There are both disease-modifying and symptom-reducing treatments available and emerging treatment possibilities.

Vanessa Baute Penry, MD, and Rachana Gandhi Mehta, MD

Amyotrophic Lateral Sclerosis

There are both disease-modifying and symptom-reducing treatments available and emerging treatment possibilities.

Zachary S. Gillis, BS, and Michael S. Cartwright, MD, MS

Spinal Muscular Atrophy

A review of available treatments.

Diana Castro, MD

Case Report

Symptoms of Lewy Body Dementia Induced by Herpes Zoster Encephalitis

Ryan Verity, MD; Andrew Kirk, MD, FRCPC; and Gary Hunter, MD, FRCPC, CSCN(EEG)

Columns

Movement Disorders Moment: Teleneurology for Movement Disorders

Teleneurologic care for movement disorders can help address a care gap and may improve quality of life.

Erin Furr Stimming, MD, and Jorge Patiño, MD

Headache Horizons: The Hateful Eight

The mind keeps score with trauma, pain syndromes, and headache.

Peter McAllister, MD

Dementia Insights: Language and Dementia

Who can take us seriously when we are so far from who we once were?; Everything she did and loved, everything she was, required language. -Lisa Genova, Still Alice.

Farhat Husain, MD; Divya Singhal, MD; and Sergio Ramirez Salazar, MD